Zoe Coughlin, M.S.

Senior Director CMC-GMP

Zoe Coughlin joined Immatics in July 2015 and is responsible for leading the clinical manufacturing of multiple adoptive cell therapy programs for various solid cancers. In this role, she has helped guide all Immatics’ active clinical trials through pre-clinical development, IND approval, and patient treatment.

Zoe has more than 10 years of experience in GMP manufacturing of cell and gene therapy products. Before joining Immatics, Zoe was a Senior Clinical Cell Therapy Specialist at M.D. Anderson Cancer Center involved in the manufacture and administration of multiple cell therapy products including the Sleeping Beauty transposon-based CAR-T program.

Zoe Coughlin holds a bachelor’s degree in Microbiology from Texas A&M University and a bachelor’s degree in Clinical Laboratory Science from The University of Texas M.D. Anderson Cancer Center. Zoe also holds a master’s degree in Clinical Practice Management from Texas Tech University and maintains an MLS (ASCP)CM certification.